HOX11 is a homeodomain-containing oncogenic transcription factor that immortalizes hematopoietic precursor cells. The mechanism by which HOX11 facilitates this initial step of leukemogenesis is, however, not well understood. We have used a DNA binding site selection assay to investigate cooperative DNA binding by HOX11 with other transcription factors. A consensus sequence was derived and identi®ed as the binding site for the CCAAT-box-binding transcription factors (CTF). HOX11 was shown to interact in vitro and in vivo with CTF1. Retrovirus-mediated transduction of an antisense CTF1 cDNA dramatically reduced the proliferative capacity of HOX11-immortalized hematopoietic precursor cells. CTF1 is, therefore, the ®rst HOX11 protein partner identi®ed that plays an important role in hematopoietic precursor cell immortalization.
Introduction
Leukemia is the most frequently occurring cancer among children. Molecular genetic analysis of oncogenes associated with childhood leukemias underscores the importance of nuclear transcription factors in the malignant transformation of hematopoietic progenitor and stem cells (Cleary, 1991) . Although convincing evidence supports an essential role for oncogenic transcription factors in leukemogenesis, the molecular events leading to malignant transformation upon deregulation or mutation of the corresponding oncogenes are not well understood. The oncogenic transcription factors must crosstalk with the general transcription machinery to activate or suppress gene transcription (Tjian and Maniatis, 1994) . They presumably also interact with other known or unknown factors to regulate their target genes and modulate the status of cell proliferation and dierentiation. Elucidation of the molecular events leading to leukemia formation may lead to identi®cation of new molecular targets for the design of more eective and less toxic therapy against leukemia (Look, 1997) .
HOX11 (TCL-3) is a homeobox oncogene isolated from the breakpoint region of the t(10;14) chromosomal translocation recurring in the malignant cells of pediatric patients with T-cell acute lymphoblastic leukemia (Hanato et al., 1991; Kennedy et al., 1991; Lu et al., 1991) . Rearrangements in the 5' regulatory region caused by the t(10;14) chromosomal translocation results in elevated expression of HOX11 in leukemic cells (Lu et al., 1991) . The normal expression pattern of HOX-11 appears to be cell type-speci®c, and the cells expressing HOX-11 include hematopoietic precursor cells and T-cells (Lu et al., 1992) . The HOX-11 homeoprotein has been localized in the nucleus (Zhang et al., 1993) and acts as a transcription activator in both mammalian and yeast cells (Zhang et al., 1996) . Constitutive expression of HOX-11 in murine bone marrow cells results in immortalization of hematopoietic precursors (Hawley et al., 1994) . Progression to a fully malignant state of leukemia in reconstituted mice appears to require additional mutation(s) (Hawley et al., 1997) .
Here we investigate cooperative DNA binding by HOX11 with other transcription factors by use of a DNA binding site selection assay. A consensus sequence has been identi®ed as the binding site for the CCAAT-box-binding transcription factors (CTF). Western blot analysis has revealed that CTF1 is predominantly expressed in HOX11-immortalized hematopoietic precursor cells. HOX11 physically associates in vitro and in vivo with CTF1. Retrovirusmediated transduction of an antisense CTF1 cDNA results in dramatic reduction in the proliferative capacity of HOX11-immortalized hematopoietic precursor cells. These ®ndings suggest that HOX11 mediates hematopoietic precursor cell transformation in part through physical interaction with CTF1.
Results

Selection of the binding site for CTF by HOX11 cooperative DNA binding
Homeoproteins bind DNA and direct gene transcription by cooperative interactions with each other (Chan et al., 1994; van Dijk and Murre, 1994) or with other transcription factors (Grueneberg et al., 1995) . A puri®ed GST-HOX11 fusion protein was previously shown to bind to TAAT and TAAC sequences, the non-speci®c binding sites for clustered homeoproteins (Dear et al., 1993) . We used a DNA binding site selection assay to investigate cooperative DNA binding by HOX11 with other transcription factors. A¯ag-tagged protein construct containing the entire HOX11 coding region was produced by use of a coupled reticulocyte lysate system and incubated with a pool of 58 bp double-stranded oligonucleotides containing a 18 bp random core sequence. Protein-DNA complexes were immunoprecipitated with an anti-¯ag monoclonal antibody and protein G Sepharose beads. After six rounds of selection, the selected oligonucleotides were cloned and sequenced. Surprisingly, no sequences corresponding to a HOX11 consensus were obtained when the epitope-tagged HOX11 protein was used for site selection. Instead, a consensus sequence was derived and identi®ed as the binding site for the CCAAT-box-binding transcription factors (CTF): TGGCANNNNGCCAA ( Figure 1 ). We surmised that the binding site for CTF was detected because HOX11 was physically associated with the CTF proteins in the reticulocyte lysate. We had previously observed that the Pbx homeoprotein bound weakly to HOX11. However, addition of Pbx to the in vitro translation mix did not alter the selection for the CTF binding site. These data suggested that HOX11 preferentially associates with CTF and modulates transcription of CTF target genes.
Physical association between CTF1 and HOX11 in vivo and in vitro To obtain evidence in support of this hypothesis, we examined CTF protein expression in nuclear extracts prepared from a HOX11-immortalized hematopoietic precursor cell line, HX3 (Hawley et al., 1994) . A major protein band of 60 kD was identi®ed by Western blot analysis with a monoclonal antibody against CTF, indicating that CTF1 is predominantly expressed in HX3 cells. To test whether HOX11 binds to CTF1 in vivo, we performed Western blot analysis of CTF1 immunoprecipitates with HOX11-speci®c antibodies and observed co-immunoprecipitation of CTF1 with HOX11 ( Figure 2a) . We previously made a HOX11 mutant harboring a point mutation in the homeodomain, PM5, that shows minimum transcription activity (Zhang et al., 1996) . Co-transfection of CTF1 fused to the GAL4 activation domain and PM5 fused to the GAL4 DNA binding domain resulted in transactivation of the GAL1 promoter in yeast cells, con®rming the in vivo interaction between CTF1 and HOX11. Notable features of the HOX11 homeoprotein include the homeodomain, a glycine-proline-rich region at the amino terminus and a glutamine-rich region at the carboxyl terminus. In vitro-translated CTF1 was shown to bind to HOX11 with reference to the GST control ( Figure 2c ). The glycine-proline-rich region of HOX11 was sucient for CTF1 binding, whereas the homeodomain and the glutamine-rich region were not required for physical association with CTF1 ( Figure  2c ).
HOX11 and TFIIB bind to distinct interaction surfaces on CTF1
The proline-rich activation domain (amino acids 399 ± 499) at the carboxyl terminus of CTF1 was previously shown to physically associate with the general transcription factor, TFIIB (Kim and Roeder, 1994) . To map the domain in CTF1 required for interaction with HOX11, we made in vitro-translated CTF1 mutant proteins with deletions in the proline-rich activation domain. The labeled CTF1 mutants were incubated with glutathione-agarose beads coupled with the GST-HOX11 fusion protein. The bound proteins were eluted and analysed by SDS ± PAGE and autoradiography. Deletion of the proline-rich activation domain of CTF1 did not alter the interaction between CTF1 and HOX11 ( Figure 3 ). Further mapping showed that HOX11 bound to a region located at amino acid residues 121-210 ( Figure 3 ).
HOX11 mediates hematopoietic precursor cell immortalization by interaction with CTF1
To assess the biological signi®cance of the interaction between CTF1 and HOX11, we used the fact that immortalized hematopoietic precursor cells form colonies when grown in soft agar (Gishizky and Witte, 1992) . We introduced a recombinant retrovirus expressing an antisense CTF1 cDNA into HX3 cells, and stably transduced cells were plated in methylcellulose-containing medium. The number of hematopoietic colonies derived from cells harboring antisense CTF1 decreased by twofold; moreover, a dramatic reduction in the size of hematopoietic colonies was observed (Figure 4a ). In contrast, retrovirus-mediated transduction of the antisense CTF1 cDNA had no eect on the proliferation of PGMD1 cells (Figure 4b ), an immortalized hematopoietic precursor cell line established by constitutive expression of IL-11 (Hawley et al., 1993) . Western blotting analysis of nuclear extracts Figure 1 Identi®cation of a CTF consensus binding site by HOX11 cooperative binding assay. Double-stranded oligonucleotides containing an 18 bp random core sequence were incubated with epitope-tagged HOX11 and rabbit reticulocyte lysate. The protein-DNA complexes were isolated by immunoprecipitation with a monoclonal antibody against the¯ag tag fused to HOX11 and subsequently by protein G Sepharose beads. The bound oligonucleotides were recovered and ampli®ed by PCR. After six rounds of selection, the selected DNA was cloned, sequenced and analysed against the Genbank database. The regions showing signi®cant homology were directly aligned. The consensus sequence identi®ed as the binding site for CTF proteins are shown within the boxes Identification of a protein partner for HOX11 N Zhang et al derived from cells harboring antisense CTF1 revealed downregulation of CTF expression in both HX3 and PGMD1 cells (Figure 3c ). These results indicate that HOX11 induces hematopoietic precursor cell immortalization by a mechanism that involves speci®c interaction with CTF1. No major dierences in cell surface markers were detected between HX3 cells expressing the antisense CTF1 cDNA and control cells, as determined by¯ow cytometric analysis. We also performed DNA fragmentation analysis to assay for apoptosis. No increase in apoptotic cell death was observed.
Discussion
We have investigated cooperative DNA binding by HOX11 with other transcription factors by use of a Equal amounts of the in vitro-translated CTF1 protein (input lane) was incubated with glutathioneagarose beads bound to the GST protein, the GST-HOX11 fusion protein, and a GST-HOX11 mutant protein with deletion of the homeodomain and the glutamine-rich region of HOX11 (GST-HOX11 5'). After incubation the beads were washed for three times. The bound protein was denatured by boiling, separated by SDS ± PAGE and detected by autoradiography. Note that the amount of GST protein used was ten times higher than the GST-HOX11 fusion protein and the GST-HOX11 5' protein DNA binding site selection assay. The selection of a consensus sequence for CTF1 but not for HOX11 indicates that HOX11 may physically interact with CTF1 and mediate hematopoietic precursor cell immortalization (Figure 1 ). Several lines of evidence further support this notion. First, HOX11 interacts with CTF1 in vitro and in vivo (Figure 2) . Second, CTF1 is predominantly expressed in the immortalized hematopoietic precursor cell line, HX3. Finally, expression of an antisense CTF1 cDNA dramatically reduces the proliferative capacity of HX3 cells ( Figure  4) . Thus, for the ®rst time, we identify a transcription factor that acts as a partner in HOX11-induced immortalization of hematopoietic precursor cells.
What is the molecular mechanism by which the interaction between CTF1 and HOX11 might modulate the rate of cell proliferation? CTF1 acts as an ubiquitous transcription factor and directs expression of a variety of eukaryotic genes (Santoro et al., 1988) . Although HOX11 has previously been shown to be capable of direct DNA binding and transactivation, our current data suggest a role for HOX11 in modulating CTF1 function. We propose that such modulation of CTF1 by HOX11 may alter the transcriptional status of the target genes for CTF1 in hematopoietic precursor cells, resulting in an increase in proliferation. Consistent with this notion is the ®nding that the HOX11 protein appears to preferentially bind to endogenous CTF1 and to thus select CTF1 binding sites (Figure 1 ). Two factors in the general transcription machinery, TFIIB and TAF55, have been shown to interact with CTF1 (Kim and Figure 3 Mapping the domain in CTF1 required for interaction with HOX11. (a) Schematic representation of CTF1 mutants and summary of binding activities to HOX11. Numbers correspond to the amino-acid position within CTF1. Hatched box designates the proline-rich domain (amino acids 399 ± 499) in CTF1 required for interaction with the general transcription factor, TFIIB. (b ± d) HOX11 and TFIIB bind to distinct domains in CTF1. The full-length CTF1 cDNA and the CTF1 mutants, CTF1 1-399, CTF1 1-437, CTF1 1-210 and CTF1 1-120 were made in vitro in the presence of 35 S-methionine. The in vitro-translated proteins were incubated with the GST-HOX11 fusion protein bound to glutathione-agarose beads. After washing, the bound proteins were eluted, separated by SDS ± PAGE and detected by autoradiography. With the starting materials as reference points, retention of the labeled proteins on the anity columns was determined by a densitometer. Lane 1, full-length CTF1; lane 2, CTF1 1-399; lane 3, CTF1 1-437; lane 7, CTF1 1-210; lane 9, CTF1 1-120. Lanes 4, 5, 6, 8 and 10 represent input materials for full-length CTF1, CTF1 1-399, CTF1 1-437, CTF1 1-210 and CTF1 1-120, respectively
Identification of a protein partner for HOX11 N Zhang et al Roeder, 1994; Chiang and Roeder, 1995) . In particular, TFIIB within the TBP-DNA complexes can be recruited by CTF1 during preinitiation complex assembly (Kim and Roeder, 1994) . Our data indicate that HOX11 and TFIIB bind to distinct interaction surfaces on CTF1 (Figure 3 ). These ®ndings thus support a model in which constitutive expression of HOX11 in hematopoietic precursor cells may facilitate the formation of a multi-protein transcription complex containing CTF1 and TFIIB, deregulating transcription of CTF1 target genes and thereby initiating the series of events leading to leukemic transformation. The HOX11 gene was initially found to be elevated in expression in the malignant cells of patients with Tcell acute lymphoblastic leukemia and later cloned by molecular genetic analysis of the t(10;14) chromosomal translocation (Lu et al., 1991) . Constitutive expression of HOX11 results in immortalization of hematopoietic precursor cells (Hawley et al., 1994) . The immortalized cells display two major characteristics: increased proliferative capacity and a block to dierentiation (Hawley et al., 1994) . In this report we demonstrate that the interaction between CTF1 and HOX11 contributes to the increased proliferative capacity of hematopoietic precursor cells (Figure 4 ). On the other hand, retrovirus-mediated transduction of an anti-sense CTF1 cDNA has failed to remove the dierentiation block resulting from constitutive expression of HOX11. Our data, therefore, indicate that HOX11 acts as an oncogenic transcription factor in hematopoietic precursor cell immortalization by directing distinct signal transduction pathways in cell proliferation and dierentiation. Recently, HOX-11 has been shown to interact with the catalytic subunit of the protein phosphatase PP2A and disrupt a G 2 /M cell-cycle checkpoint (Kawabe et al., 1997) . Although a biological role for HOX11-PP2A interaction in hematopoietic precursor cell immortalization has yet to be established, this ®nding is consistent with the notion that HOX11 may promote cell cycle progression by suppressing PP2A activity in the leukemogenic process. Our observation that HOX11 undergoes cell cycle-dependent regulation further supports this hypothesis (Zhang et al., 1993) .
Homeoproteins bind DNA and direct gene transcription by cooperative interactions with each other and with other transcription factors. For example, the Ultrabithorax homeoprotein interacts cooperatively with the exd homeoprotein to enhance the DNA binding speci®city of Ultrabithorax (Chan et al., 1994; van Dijk and Murre, 1994) . The Phox1 homeoprotein and the serum response factor (SRF) interact on DNA binding to achieve transcription activation (Grueneberg et al., 1995) . A prerequisite for this type of study is that the candidate protein interaction partners must be cloned and their function as transcription factors documented. Popular methods used to identify unknown protein interaction partners include screening of lambda phage expression libraries and use of the yeast two-hybrid assay. Application of these methods is tedious and time-consuming. On the other hand, our data show that the cooperative DNA binding site selection assay can be used as a complementary method to the existing techniques designed for identi®cation of unknown protein partners that interact with a known transcription factor such as HOX11. One limitation with the use of the DNA binding site selection assay is that the protein interaction partner must act as a transcription factor and bind DNA. Nontheless, the DNA binding site selection assay can be used as a quick screening procedure to identify unknown protein interaction partners for a given transcription factor.
Materials and methods
DNA binding site selection assay
Cooperative DNA binding site selection was performed as previously described (Shen et al., 1997) . Brie¯y, a full-length HOX11 cDNA (Lu et al., 1991) was cloned into the sp65 vector (Promega) engineered to express proteins containing an N-terminal¯ag epitope sequence (MDYKDDDDK). The recombinant plasmid DNA was incubated with a coupled reticulocyte lysate system (Promega) in presence of SP6 RNA polymerase. The in vitro-translated HOX11 protein was veri®ed by Western blot analysis with antibodies against HOX11 (Zhang et al., 1993) . The in vitro translation mix was subsequently incubated with a pool of double-stranded oligonucleotides containing an 18 bp random core sequence (GCTCGAATTCAAGCTT-CTN18CATGGATCCTGCAGAATTCAGT) and immunoprecipitated with an anti-¯ag monoclonal antibody and protein G Sepharose beads. The selected oligonucleotides were ampli®ed by 20 cycles of polymerase chain reaction (948C, 1 min; 548C, 1 min; 728C, 1 min), using primers designed against the¯anking arms. After six selection cycles, the ampli®ed DNA was cloned, sequenced and searched against Genbank database.
GST pull-down assay
The HOX-11 cDNA was fused in frame with the GST gene in pGEX-2T (Pharmacia). The ligated plasmid DNA was transformed and ampli®ed in the bacterial strain, RR1. Bacteria containing the recombinant plasmid was cultured overnight, diluted 1 : 10 into medium containing IPTG, grown for 3 h, lysed by sonication and passed through a glutathione anity column. The glutathione beads were incubated with labeled CTF1 protein made by in vitro translation in the presence of 35 S-methionine.
Immunoprecipitation and Western blot analysis
The immortalized hematopoietic precursor cells, HX3 and PGMD1, were washed with phosphate buered saline (PBS) and lysed by incubation on ice for 10 min in 150 mM NaCl, 0.025% NP-40, 50 mM Tris (pH 8.0) and 5 mM phenylmethysulfonyl¯uoride (PMSF). The nuclei were pelleted at 1000 g for 5 min, washed, and resuspended in lysis buer containing 1% NP-40. After removal of cell debris by centrifugation, the nuclear extracts were incubated with anti-CTF IgG for 1 h at 48C. Protein A beads were added and the immune complexes incubated for 1 h at 48C with rocking. After washing for three times with lysis buer, the protein A beads were collected by centrifugation, added with Laemmli sample buer and heated at 858C for 10 min. The supernatants were collected, loaded on SDS-polyacrylamide gels and probed by incubation with anti-HOX11 antibodies as described (Zhang et al., 1993) .
Retrovirus-mediated gene transduction
The CTF1 cDNA in Bluescript SK + (Santoro et al., 1988 ) was digested with BamHI, blunted with the Klenow fragment and cloned, in the antisense orientation, into the MSCV retroviral vector (Hawley et al., 1994) . Recombinant retroviruses were produced using the PA317 amphotropic packaging cell line. Virus-producing PA317 cells were grown in Dulbecco's modi®ed Eagle's medium with high glucose and 10% fetal calf serum. Viral supernatants were collected, ®ltered and stored in aliquots at 7808C. The viral titer was determined by infection of NIH3T3 cells to range from 5610 5 to 2610 6 c.f.u./ml. HX3 and PGMD1 cells were incubated for 15 h at 378C with the viral supernatant in the presence of Polybrene (6 mg/ml). A multiplicity of infection (moi) of two was used in all experiments. After incubation, cells were pelleted by centrifugation, resuspended, counted, and plated in methylcellulose cultures with G418.
